Apnimed Named 2024 Best Places to Work Company by the Boston Business Journal
CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- The Boston Business Journal has named Apnimed, Inc., a clinical-stage pharmaceutical company focused on...
Month: May 2024
Sirona Biochem Engages Stonegate Healthcare Partners
VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) has announced...
Windtree Therapeutics Regains Compliance with Nasdaq
WARRINGTON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company...
RadNet’s Lenox Hill Radiology to Host Mother’s Day Mammogram Screening Parties in New York City
WNBA icon Sheryl Swoopes and New York elected officials will attend “MammoGlam” events in Harlem and the Bronx to promote...
Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment
Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
IRVINE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the...
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated...
Arbutus to Participate in Two Upcoming Investor Conferences
WARMINSTER, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive...
Altimmune to Participate at Two Upcoming Investor Conferences
GAITHERSBURG, Md., May 07, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members...
Enable Injections Expands Strategic Partnership with Roche
CINCINNATI, May 07, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse® platform of...
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report
FORT MILL, SC / ACCESSWIRE / May 6, 2024 / Catheter Precision, Inc. (NYSE American:VTAK) a MedTech company pioneering products...
TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call
Call Scheduled for Wednesday, May 15, 2024, at 9:00 a.m. ETDENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company...
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides significant improvement in...
TruBridge to Webcast Its First Quarter 2024 Conference Call
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge (NASDAQ: TBRG), a healthcare solutions company, today announced that it will release its financial results for the...
NHI Announces Second Quarter 2024 Dividend
MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay...
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI
Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations...
Four Groundbreaking Studies From NGS Pioneers MicroGenDX Were Presented for the First Time to Attendees of the Wound Healing Society 2024
Findings From These Studies Could Save Thousands of Lives Through Better Understanding the Mechanistic Basis of Chronic Wound InfectionORLANDO, FL...
Model N Announces Second Quarter Fiscal Year 2024 Financial Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), a leader in cloud revenue management solutions, today announced financial results for...
Leopoly Introduces LeoShape: Transforming Orthotics & Prosthetics with Cutting-Edge 3D Design Tech, Revolutionizing The Industry
LeoShape, from Leopoly, Introduces Innovative 3D Platform for Custom Orthotics & Prosthetics Design, Offering Free Trials in May SAN MATEO,...
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
WOBURN, MA / ACCESSWIRE / May 6, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of...